|
Valoración de DCF Standard BioTools Inc. (LAB)
US | Healthcare | Medical - Diagnostics & Research | NASDAQ
|
- ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
- ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
- ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
- ✓ No Se Necesita Experiencia; Fáciles De Seguir
Standard BioTools Inc. (LAB) Bundle
¡Optimice su tiempo y mejore la precisión con nuestra calculadora DCF (LAB)! Utilizando datos auténticos estándar BioTools Inc. y supuestos personalizables, esta herramienta le permite pronosticar, analizar y valor (LAB) al igual que un inversor experimentado.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 117.2 | 138.1 | 130.6 | 97.9 | 106.3 | 105.3 | 104.2 | 103.1 | 102.1 | 101.0 |
| Revenue Growth, % | 0 | 17.83 | -5.47 | -24.99 | 8.57 | -1.02 | -1.02 | -1.02 | -1.02 | -1.02 |
| EBITDA | -46.6 | -34.6 | -43.8 | -173.6 | -54.5 | -52.5 | -52.0 | -51.5 | -50.9 | -50.4 |
| EBITDA, % | -39.76 | -25.05 | -33.52 | -177.21 | -51.21 | -49.91 | -49.91 | -49.91 | -49.91 | -49.91 |
| Depreciation | 15.8 | 17.9 | 16.1 | 15.0 | 15.2 | 14.4 | 14.3 | 14.1 | 14.0 | 13.8 |
| Depreciation, % | 13.48 | 12.99 | 12.31 | 15.34 | 14.27 | 13.68 | 13.68 | 13.68 | 13.68 | 13.68 |
| EBIT | -62.4 | -52.5 | -59.8 | -188.6 | -69.6 | -63.7 | -63.1 | -62.4 | -61.8 | -61.1 |
| EBIT, % | -53.24 | -38.04 | -45.82 | -192.55 | -65.49 | -60.52 | -60.52 | -60.52 | -60.52 | -60.52 |
| Total Cash | 58.6 | 68.5 | 28.5 | 165.8 | 114.9 | 67.7 | 67.0 | 66.3 | 65.6 | 64.9 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 19.0 | 25.4 | 18.3 | 17.3 | 19.7 | 17.8 | 17.7 | 17.5 | 17.3 | 17.1 |
| Account Receivables, % | 16.19 | 18.4 | 14.03 | 17.64 | 18.49 | 16.95 | 16.95 | 16.95 | 16.95 | 16.95 |
| Inventories | 13.9 | 19.7 | 20.8 | 21.5 | 20.5 | 17.5 | 17.4 | 17.2 | 17.0 | 16.8 |
| Inventories, % | 11.84 | 14.25 | 15.95 | 21.92 | 19.31 | 16.65 | 16.65 | 16.65 | 16.65 | 16.65 |
| Accounts Payable | 5.2 | 9.2 | 10.6 | 7.9 | 9.2 | 7.6 | 7.5 | 7.4 | 7.3 | 7.3 |
| Accounts Payable, % | 4.39 | 6.67 | 8.12 | 8.08 | 8.69 | 7.19 | 7.19 | 7.19 | 7.19 | 7.19 |
| Capital Expenditure | -2.5 | -12.7 | -13.3 | -3.8 | -2.8 | -5.9 | -5.9 | -5.8 | -5.7 | -5.7 |
| Capital Expenditure, % | -2.16 | -9.21 | -10.16 | -3.91 | -2.66 | -5.62 | -5.62 | -5.62 | -5.62 | -5.62 |
| Tax Rate, % | -0.60913 | -0.60913 | -0.60913 | -0.60913 | -0.60913 | -0.60913 | -0.60913 | -0.60913 | -0.60913 | -0.60913 |
| EBITAT | -60.6 | -51.5 | -55.7 | -185.8 | -70.1 | -62.0 | -61.4 | -60.8 | -60.1 | -59.5 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -75.1 | -54.5 | -45.5 | -176.9 | -57.8 | -50.4 | -52.7 | -52.2 | -51.6 | -51.1 |
| WACC, % | 8.88 | 8.9 | 8.8 | 8.91 | 8.93 | 8.88 | 8.88 | 8.88 | 8.88 | 8.88 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -201.2 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | -52 | |||||||||
| Terminal Value | -757 | |||||||||
| Present Terminal Value | -495 | |||||||||
| Enterprise Value | -696 | |||||||||
| Net Debt | 47 | |||||||||
| Equity Value | -742 | |||||||||
| Diluted Shares Outstanding, MM | 79 | |||||||||
| Equity Value Per Share | -9.38 |
What You Will Get
- Editable Excel Template: A fully customizable Excel-based DCF Calculator featuring pre-filled real LAB financials.
- Real-World Data: Access to historical data and forward-looking estimates (highlighted in the yellow cells).
- Forecast Flexibility: Adjust forecast assumptions such as revenue growth, EBITDA %, and WACC.
- Automatic Calculations: Instantly observe the effects of your inputs on Standard BioTools Inc.'s valuation.
- Professional Tool: Designed for investors, CFOs, consultants, and financial analysts.
- User-Friendly Design: Organized for clarity and ease of use, complete with step-by-step instructions.
Key Features
- Comprehensive DCF Calculator: Offers detailed unlevered and levered DCF valuation models tailored for Standard BioTools Inc. (LAB).
- WACC Calculator: Features a pre-built Weighted Average Cost of Capital sheet with adjustable inputs specific to the biotech sector.
- Customizable Forecast Assumptions: Easily alter growth rates, capital expenditures, and discount rates according to your analysis needs.
- Integrated Financial Ratios: Evaluate profitability, leverage, and efficiency ratios relevant to Standard BioTools Inc. (LAB).
- Interactive Dashboard and Charts: Visual representations summarize essential valuation metrics for straightforward analysis.
How It Works
- Download the Template: Gain immediate access to the Excel-based LAB DCF Calculator.
- Input Your Assumptions: Modify the yellow-highlighted cells for growth rates, WACC, margins, and other variables.
- Instant Calculations: The model automatically recalculates Standard BioTools Inc.’s intrinsic value.
- Test Scenarios: Explore various assumptions to assess potential changes in valuation.
- Analyze and Decide: Utilize the outcomes to inform your investment or financial analysis.
Why Choose This Calculator for Standard BioTools Inc. (LAB)?
- Accurate Data: Real Standard BioTools Inc. financials provide trustworthy valuation outcomes.
- Customizable: Modify essential parameters such as growth rates, WACC, and tax rates to fit your forecasts.
- Time-Saving: Pre-configured calculations save you the hassle of starting from the beginning.
- Professional-Grade Tool: Tailored for investors, analysts, and consultants in the biotech sector.
- User-Friendly: Clear layout and guided instructions ensure accessibility for all users.
Who Should Use Standard BioTools Inc. (LAB)?
- Researchers: Enhance your experiments with advanced tools for biological analysis.
- Laboratory Managers: Streamline operations using our comprehensive product suite tailored for efficiency.
- Biotechnology Firms: Integrate our solutions into your workflows for improved data accuracy.
- Students and Educators: Utilize our resources for hands-on learning in biology and biotechnology courses.
- Healthcare Professionals: Leverage our innovative technologies to support diagnostics and patient care.
What the Template Contains
- Comprehensive DCF Model: Editable template featuring detailed valuation calculations.
- Real-World Data: Standard BioTools Inc.'s (LAB) historical and projected financials preloaded for analysis.
- Customizable Parameters: Modify WACC, growth rates, and tax assumptions to explore various scenarios.
- Financial Statements: Complete annual and quarterly breakdowns for enhanced insights.
- Key Ratios: Integrated analysis for profitability, efficiency, and leverage metrics.
- Dashboard with Visual Outputs: Charts and tables that provide clear, actionable results.